Press "Enter" to skip to content

New patent for BDSI drug SYMPROIC

0
Copyright © DrugPatentWatch. Originally published at New patent for BDSI drug SYMPROIC

Annual Drug Patent Expirations for SYMPROIC
Annual Drug Patent Expirations for SYMPROIC

Symproic is a drug marketed by Bdsi and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.

SYMPROIC drug price trends.

This drug has fifty-five patent family members in twenty-five countries.

The generic ingredient in SYMPROIC is naldemedine tosylate. One supplier is listed for this compound. Additional details are available on the naldemedine tosylate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for BDSI drug SYMPROIC
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    DrugPatentWatch - Make Better Decisions